Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • anjama
    Member
    • Mar 2016
    • 15

    qubit and picogreen discrepancies

    We're a small lab that has done most of our quantitation using nanodrop and qubit, depending on the application. However, as we try to prepare multiplexed illumina libraries for dsDNA, we're trying to get a picogreen up and running. After some tech support help we were able to get a beautiful standard curve that seemed to be working well. But then we decided to double check our samples using the qubit, and found some very significant discrepancies. Some samples had similar readings on both machines, others would be tens of ng lower on the qubit, and yet others would be tens of nanograms higher on the qubit. So the concentration readings aren't consistently off in one direction or the other.

    We double checked the raw qubit standards and 2 sets of raw picogreen standards on the nanodrop, and all the readings were 92 ng/ul give or take a ng, so the standards seem to be consistent, and we're assuming the nanodrop is just underestimating them slightly. But when we tried qubiting the pico standard, it was about 86 ng/ul. When we tried replicating samples on the picogreen with the same standards, the values were sometimes significantly different.

    We're trying our best to ensure that all samples and standards are incubated to the same temperature for the same amount of time. We also do our best to minimize light exposure, even going so far as to pipette into the picogreen plates with the lights off and only a little ambient light coming in through closed shades

    Any thoughts or suggestions on what we might be doing wrong or things we could try would be appreciated. Thanks.
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    Some possible causes:

    1- variation in pipetting and pipette being out of calibration
    2- using low sample volume. For comparisons it is better to use minimum 3ul sample or the standard with two replicates
    3- using unsuitable Qubit reagent and buffer, best practice would be using sample with concentration around 10 ng/ul with HS reagents

    Comment

    • thermophile
      Senior Member
      • Apr 2015
      • 243

      #3
      Remember quibit is a single point calibration (with blank-s1 0ng, s2 10ng). So the further you are from 10ng/ul the worse the quantification will be. Are you doing replicates with your picogreen? (you can do 25ul diluted dye, 25ul diluted DNA in 384 well plates to minimize costs and allow you to do replicates)

      The nanodrop is going to be way off, don't worry about the numbers it comes up with.
      Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

      Comment

      • anjama
        Member
        • Mar 2016
        • 15

        #4
        Thanks for the input. Based on input here and experimenting in the lab, it looks like we'll be incorporating replication into our Picogreen protocol to ensure good consistency.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          Yesterday, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:10 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        41 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...